By Stephanie Armour and Andrew Restuccia
WASHINGTON -- The Trump administration defended its coronavirus
response and rejected the idea of appointing a czar to oversee the
effort to stop the outbreak from spreading, while Democratic and
Republican lawmakers looked to boost emergency funding beyond
President Trump's $2.5 billion spending plan.
The fast-moving developments came a day after a top health
official warned businesses, schools and communities to brace
themselves and plan for potential outbreaks. U.S. stocks gave up
early gains Wednesday after dropping sharply in previous days amid
concerns about the coronavirus's economic impact.
Health and Human Services Secretary Alex Azar currently leads a
federal coronavirus task force, but some Republicans, including
Sens. Rick Scott of Florida and Mitt Romney of Utah, have joined
Democrats in calling for a coronavirus czar to oversee operations.
Administration officials have privately discussed appointing a czar
to oversee the response, according to two people familiar with the
conversations.
But White House officials said Wednesday that Mr. Trump has no
plans to name such a czar. Mr. Trump took "decisive action by
creating the Coronavirus Virus Task Force a month ago and is
pleased with the leadership of @SecAzar to protect the public
health," tweeted White House spokesman Judd Deere.
On Wednesday, Mr. Azar also disagreed with the need for a czar,
saying at a House hearing that his agency is designated as the lead
under a national response plan. He called the decision to name an
Ebola czar during the Obama administration an "oddity." In his
testimony, Mr. Azar said operations were running smoothly.
Mr. Trump, who returned from a trip to India Wednesday morning,
again defended his administration's response, accusing Democrats
and the media of exaggerating the threat.
The president plans to hold a news conference at 6:30 p.m. ET at
the White House to discuss the virus alongside representatives of
the Centers for Disease Control and Prevention.
Mr. Trump said media outlets were "doing everything possible to
make the Caronavirus look as bad as possible, including panicking
markets, if possible."
The discussions about appointing a czar reflect discontent in
some corners of the administration about Mr. Azar from before the
coronavirus outbreak. Mr. Azar has at times butted heads with other
senior administration officials.
Planning for the coronavirus has been hampered by haphazard
communications with the federal government, according to people
familiar with the planning. Some state leaders also say the lack of
a coronavirus czar to head operations has Trump administration
agency heads and advisers clashing over who is in charge.
"I'm not satisfied with the response from the federal
government," Sen. Brian Schatz (D., Hawaii) said in a recent radio
interview. "There has been a total lack of communication,
especially between our federal officials and state officials."
On Wednesday, a CDC official warned that the agency expects a
sustained transmission of the virus. "It's not so much a question
of if this will happen any more, but rather more a question of
exactly when," said Nancy Messonnier, director of the CDC's
National Center for Immunization and Respiratory Diseases.
On Capitol Hill, negotiations on funding a response to the
disease began, with staff from both chambers and parties meeting
Wednesday. The Trump administration's proposal to spend at least
$2.5 billion on combatting coronavirus -- with $1.25 billion in new
funds and at least $1.25 billion in repurposed funds -- has
disappointed members of both parties.
"This is shameful, it puts forth a proposal now that is meager,
anemic," House Speaker Nancy Pelosi (D., Calif.) said of the
administration's plan Wednesday.
"We will work on it, but it will be higher than what they've
got," Senate Appropriations Chairman Richard Shelby (R., Ala.)
said, referring to the Trump proposal. "We will make sure that
we've got the resources without any doubt."
Senate Minority Leader Chuck Schumer (D., N.Y.) proposed his own
$8.5 billion emergency spending package on Wednesday.
House Minority Leader Kevin McCarthy (R., Calif.) said Wednesday
that he expected the package to come in around $4 billion.
In the U.S., 15 locally diagnosed cases have been confirmed,
with an additional 40 from the outbreak on the Diamond Princess
cruise ship in Asia and three among Americans who returned from
China aboard U.S.-chartered flights.
More than 2,700 people have died globally as a result of the
virus, which is said to have originated in China and has spread to
Iran, Italy, South Korea and other countries. A 23-year-old
American soldier stationed in South Korea became the first U.S.
service member to contract the virus.
In congressional testimony Wednesday, Mr. Azar stressed the low
number of diagnosed cases. Problems with coronavirus tests have
postponed broader surveillance. Authorities have tested about 400
people in the U.S. for the virus.
"The immediate risk to the American public remains low, but
there is now community transmission in a number of countries
outside Asia that is deeply concerning," Mr. Azar said at a House
Appropriations subcommittee hearing, adding that "we expect to see
more cases here."
Mr. Azar said money from the emergency funding request would be
used for a fund at the CDC to reimburse state and local agencies.
There are 20 pharmaceutical products where the entire product is
made in China or an active ingredient sold in China, where
businesses have been hit hard by the outbreak, but Mr. Azar said
officials aren't aware of any shortages.
Already, the administration has transferred about $140 million
from the Department of Health and Human Services toward fighting
the virus, including $60 million from the National Institutes of
Health and $40 million from that helps low-income Americans with
energy bills.
--Andrew Duehren contributed to this article.
Write to Stephanie Armour at stephanie.armour@wsj.com and Andrew
Restuccia at Andrew.Restuccia@wsj.com
(END) Dow Jones Newswires
February 26, 2020 16:30 ET (21:30 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.